Ying Cheng Selected Research

Ying Cheng Research Topics

Disease

144	Neoplasms (Cancer) 05/2024 - 11/2007
104	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2024 - 05/2012
46	Disease Progression 12/2023 - 05/2012
43	Neoplasm Metastasis (Metastasis) 01/2024 - 12/2008
34	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2024 - 05/2014
31	Hypertension (High Blood Pressure) 05/2024 - 05/2005
29	Inflammation (Inflammations) 10/2023 - 08/2004
27	Lung Neoplasms (Lung Cancer) 04/2024 - 04/2014
24	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 10/2012
22	Infections 05/2024 - 11/2004
17	Breast Neoplasms (Breast Cancer) 10/2023 - 07/2010
16	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 09/2013
14	Stomach Neoplasms (Stomach Cancer) 03/2024 - 12/2008
13	Adenocarcinoma of Lung 12/2023 - 07/2013
12	Diarrhea 01/2023 - 01/2017
11	Hypoxia (Hypoxemia) 05/2024 - 05/2012
11	Adenocarcinoma 05/2024 - 02/2005
11	Brain Neoplasms (Brain Tumor) 04/2024 - 01/2017
11	Carcinoma (Carcinomatosis) 01/2023 - 12/2008
11	Type 2 Diabetes Mellitus (MODY) 03/2022 - 01/2019
10	Reperfusion Injury 01/2023 - 08/2004
10	Exanthema (Rash) 11/2022 - 05/2012
8	Body Weight (Weight, Body) 04/2024 - 12/2007
8	Neutropenia 12/2023 - 01/2018
8	Fibrosis (Cirrhosis) 01/2023 - 01/2018
7	COVID-19 05/2024 - 12/2020
7	Proteinuria 02/2024 - 01/2015
7	Cholestasis 01/2023 - 01/2015
7	Death (Near-Death Experience) 10/2021 - 12/2016
6	Pain (Aches) 04/2024 - 11/2008
6	Leukemia 11/2023 - 04/2016
6	Ischemia 08/2023 - 06/2008
6	Nausea 12/2022 - 04/2014
6	Hand-Foot Syndrome 01/2021 - 12/2008
5	Carcinogenesis 03/2024 - 04/2011
5	Thyroid Neoplasms (Thyroid Cancer) 10/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

44	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2005
33	ErbB Receptors (EGF Receptor)IBA 07/2024 - 06/2013
31	Tyrosine Kinase InhibitorsIBA 07/2024 - 06/2013
30	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2014
25	anlotinibIBA 10/2023 - 01/2018
21	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 12/2008
18	MicroRNAs (MicroRNA)IBA 02/2024 - 04/2011
18	Gefitinib (Iressa)FDA Link 11/2022 - 05/2012
17	PlatinumIBA 03/2024 - 05/2012
17	Messenger RNA (mRNA)IBA 03/2024 - 11/2004
14	Immune Checkpoint InhibitorsIBA 05/2024 - 09/2017
14	Therapeutic UsesIBA 03/2024 - 11/2011
14	Docetaxel (Taxotere)FDA Link 01/2024 - 07/2010
13	Alanine Transaminase (SGPT)IBA 02/2024 - 12/2008
13	osimertinibIBA 02/2024 - 11/2018
12	NivolumabIBA 02/2024 - 10/2017
11	LigandsIBA 04/2024 - 05/2014
11	Fluorouracil (Carac)FDA LinkGeneric 01/2024 - 02/2005
11	B7-H1 AntigenIBA 01/2023 - 11/2017
10	camrelizumabIBA 05/2024 - 01/2021
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 02/2005
10	CytokinesIBA 01/2023 - 11/2011
10	LipidsIBA 01/2022 - 02/2012
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024 - 10/2012
9	Pemetrexed (MTA)FDA Link 02/2024 - 09/2014
9	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 01/2009
9	Capecitabine (Xeloda)FDA Link 01/2023 - 12/2008
8	pembrolizumabIBA 04/2024 - 10/2017
8	Anaplastic Lymphoma KinaseIBA 04/2024 - 01/2019
8	Carboplatin (JM8)FDA LinkGeneric 11/2023 - 09/2014
8	Bevacizumab (Avastin)FDA Link 01/2023 - 03/2012
8	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 06/2015
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 10/2013
8	dicarboxydine (DCD)IBA 10/2021 - 12/2016
7	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2022
7	Hormones (Hormone)IBA 02/2024 - 01/2019
7	Gemcitabine FDA Link 11/2023 - 09/2014
7	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 01/2015
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2014
7	apatinibIBA 01/2023 - 09/2013
7	Transcription Factors (Transcription Factor)IBA 07/2020 - 01/2015
6	Phosphotransferases (Kinase)IBA 05/2024 - 01/2017
6	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2024 - 09/2017
6	Long Noncoding RNAIBA 02/2024 - 01/2017
6	CrizotinibIBA 01/2024 - 01/2019
6	Angiotensin IIIBA 12/2023 - 09/2009
6	Paclitaxel (Taxol)FDA LinkGeneric 10/2023 - 09/2010
6	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 03/2014
6	Insulin (Novolin)FDA Link 03/2022 - 05/2007
6	Blood Glucose (Blood Sugar)IBA 03/2022 - 12/2007
6	empagliflozinIBA 01/2022 - 01/2019
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 04/2016
6	LipopolysaccharidesIBA 10/2021 - 10/2011
5	toripalimabIBA 05/2024 - 01/2022
5	Etoposide (VP 16)FDA LinkGeneric 03/2024 - 04/2016
5	6-methyladenineIBA 03/2024 - 01/2020
5	Monoclonal AntibodiesIBA 01/2024 - 12/2019
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2024 - 01/2015
5	Triglycerides (Triacylglycerol)IBA 11/2023 - 01/2012

Therapy/Procedure

107	Drug Therapy (Chemotherapy) 05/2024 - 12/2008
105	Therapeutics 05/2024 - 08/2003
25	Immunotherapy 05/2024 - 06/2014
10	Radiotherapy 12/2023 - 04/2014
6	Transplantation 05/2024 - 08/2004